Perseus Proteomics

4882.TTSE GROWTHPharmaceutical

Key numbers · FY ended 2026-03

Revenue¥136m+12.6% YoY Operating income−¥745m—Total assets¥1.6bn-10.7% YoY EPS (basic)¥-48.17+24.0% YoY

Full financial history and reports →

Stock price4882 · View chart ↗

Open the price chart on TradingView.

Latest filings

Fri, Jul 3 · JST1 filing

15:395% STAKEPerseus Proteomics · Macquarie Bank Limited · 8.15% → 0.63%−7.52pp

Tue, Apr 21 · JST1 filing

10:225% STAKEPerseus Proteomics · NOMURA INTERNATIONAL PLC + 1 joint holder · 7.24% → 0.99%−6.25pp

Mon, Mar 16 · JST1 filing

15:355% STAKEPerseus Proteomics · Macquarie Bank Limited · 10.77% → 8.15%−2.62pp

Fri, Mar 13 · JST1 filing

16:215% STAKEPerseus Proteomics · Macquarie Bank Limited · 17.95% → 10.77%−7.18pp

Wed, Mar 11 · JST1 filing

16:055% STAKEPerseus Proteomics · Macquarie Bank Limited · 19.44% → 17.95%−1.49pp

All filings →

Major holders (5%+) · 0

Holder	Stake	Change	Filed

No holder currently reports 5% or more.

Each holder's own ratio from its most recent large-shareholding report.